Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 312

Francesca Domenech Wuttke, new Chief Digital Officer and new member of the Management Board in Almirall

Posted by fidest press agency su sabato, 5 gennaio 2019

Almirall, S.A. has announced the appointment of Francesca Domenech Wuttke as the new Chief Digital Officer and member of the Management Board of the company.
In her new role, Francesca Domenech Wuttke will report directly to Peter Guenter, Chief Executive Officer, Almirall, and will be responsible for developing and executing the end-to-end digital strategy, a key pillar in the future success of Almirall.She will lead the Digital Transformation for Almirall, defining the new digital governance model, developing and prioritizing the enterprise wide Digital Project Portfolio and working closely with all business stakeholders.“Digital transformation in healthcare is a huge opportunity for any biopharmaceutical company. We are certain that Francesca is the best person to lead the transformation with Almirall”, explained Peter Guenter, Chief Executive Officer, Almirall. “She will join us after more than 25 years of international strategic, commercial and transactional experience. She has excellent firsthand knowledge of the potential that digital technology has in the healthcare industry, so we are fortunate to have her”.During the last few years, Francesca has led European investments as Managing Director Europe for the Global Health Innovation Fund MSD’s venture capital arm. The fund is exclusively focused on investments in digital health solutions and services and there, she designed the investment thesis to accelerate the digital clinical trial ecosystem, with much success. For example, she invested in a digital clinical trial patient recruitment platform as well as a platform that interrogates electronic medical records for genomic phenotyping, clinical trial applications and Real World Evidence. Previously, she also worked as Global Director, Commercial Strategy at Novartis and she was co-founder of Asten BioPharma Avisors, a healthcare consultancy that supports business development of biopharmaceutical companies interested in investments in biotechnology. During her experience in venture capital, private equity, start-ups, consulting and pharma companies, Francesca has shown a great ability to distill scientific and clinical data into investment opportunities, having prospected and evaluated hundreds of opportunities.Francesca holds a PhD in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a B.A. in Biology and Society by the Cornell University College of Arts and Sciences. Francesca is an American citizen who lives with her family in Barcelona.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: